▶ 調査レポート

放射性医薬品のアメリカ市場2017

• 英文タイトル:United States Radiopharmaceutical Industry 2017 Market Research Report

QYResearchが調査・発行した産業分析レポートです。放射性医薬品のアメリカ市場2017 / United States Radiopharmaceutical Industry 2017 Market Research Report / A042124079資料のイメージです。• レポートコード:A042124079
• 出版社/出版日:QYResearch / 2017年4月6日
• レポート形態:英文、PDF、144ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥410,400 (USD3,800)▷ お問い合わせ
  Enterprise¥820,800 (USD7,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、放射性医薬品のアメリカ市場について調査・分析し、放射性医薬品のアメリカ市場概観、放射性医薬品の種類別市場分析、用途別市場分析、放射性医薬品のアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・放射性医薬品のアメリカ市場概観
・放射性医薬品の種類別市場規模
・放射性医薬品の用途別市場規模
・放射性医薬品のアメリカ市場規模
・放射性医薬品のアメリカ市場予測
・放射性医薬品の製造メーカー分析
・放射性医薬品のメーカー別生産量
・放射性医薬品のメーカー別市場シェア
・放射性医薬品の価格動向・価格分析
・放射性医薬品の販売(売上高)動向
・放射性医薬品の貿易(輸出・輸入)動向
・放射性医薬品の産業チェーン分析
・放射性医薬品のマーケティング戦略分析
・放射性医薬品の販売業者(代理店)リスト
・放射性医薬品の市場環境分析
...

In the last several years, United States market of radiopharmaceuticals developed smoothly, with an average growth rate of 7.6%. In 2016, United States revenue of radiopharmaceuticals is nearly 1.7 billion USD.
In the future, United States market is expected to witness significant growth on account of rising cancer and cancer patients, so in the next few years, radiopharmaceuticals revenue will show a trend of steady growth. In 2022 the revenue of radiopharmaceuticals is estimated to be 2.4 billion USD.

The major players in United States Radiopharmaceuticals market include
Bayer
Triad Isotopes
Lantheus
GE Healthcare
Mallinckrodt
Eli Lilly
Bracco Imaging
SIEMENS
Navidea
Nordion
IBA Group
Jubilant Pharma

On the basis of product, the Radiopharmaceuticals market is primarily split into
Diagnostic Radioisotopes
Therapeutic Radioisotopes

On the basis on the applications, this report covers
Oncology
Cardiology
Other

レポート目次

Table of Contents

1 Industry Overview 1
1.1 Definition and Specifications of Radiopharmaceuticals 1
1.1.1 Definition of Radiopharmaceuticals 1
1.1.2 Specifications of Radiopharmaceuticals 1
1.2 Classification of Radiopharmaceuticals 3
1.2.1 Diagnostic Radioisotopes 4
1.2.2 Therapeutic Radioisotopes 5
1.3 Applications of Radiopharmaceuticals 5
1.3.1 Oncology 7
1.3.2 Cardiology 7
1.3.3 Other 8
1.4 Industry Chain Structure of Radiopharmaceuticals 9
1.5 Industry Regional Overview of Radiopharmaceuticals 10
1.6 Industry Policy Analysis of Radiopharmaceuticals 11
1.7 Industry News Analysis of Radiopharmaceuticals 12
2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals 15
2.1 Raw Material and Suppliers 15
2.2 Equipment Suppliers Analysis of Radiopharmaceuticals 15
2.3 Labor Cost Analysis of Radiopharmaceuticals 16
2.4 Other Costs Analysis 18
2.4.1 USA Cost of Electricity Analysis 18
2.4.2 USA Water Cost Analysis 18
2.5 Manufacturing Cost Structure Analysis of Radiopharmaceuticals 19
2.6 Manufacturing Process Analysis of Radiopharmaceuticals 20
2.7 United States Price, Cost and Gross of Radiopharmaceuticals 2012-2017 21
3 Technical Data and Manufacturing Plants Analysis of Radiopharmaceuticals 23
3.1 Capacity and Established Date of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 23
3.2 Headquarter of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 23
3.3 R&D Status/Revenue and Sales Region of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 24
4 Production Analysis of Radiopharmaceuticals by Regions, Technology, and Applications 25
4.1 United States Production of Radiopharmaceuticals by Regions 2012-2017 25
4.2 United States Production of Radiopharmaceuticals by Product Types 2012-2017 29
4.3 United States Sales of Radiopharmaceuticals by Applications 2012-2017 32
4.4 Price Analysis of United States Radiopharmaceuticals Key Manufacturers in 2016 36
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Radiopharmaceuticals 2012-2017 36
5 Consumption Volume and Consumption Value Analysis of Radiopharmaceuticals by Regions 38
5.1 United States Consumption Volume of Radiopharmaceuticals by Regions 2012-2017 38
5.2 United States Consumption Value of Radiopharmaceuticals by Regions 2012-2017 42
5.3 United States Consumption Price Analysis of Radiopharmaceuticals by Regions 2012-2017 46
6 Analysis of Radiopharmaceuticals Production, Supply, Sales and Market Status 2012-2017 47
6.1 Capacity, Production, Sales, and Revenue of Radiopharmaceuticals 2012-2017 47
6.2 Production Market Share and Sales Market Share of Radiopharmaceuticals 2012-2017 53
6.3 Sales Overview of Radiopharmaceuticals 2012-2017 60
6.4 Supply, Consumption and Gap of Radiopharmaceuticals 2012-2017 61
6.5 Import, Export and Consumption of Radiopharmaceuticals 2012-2017 62
6.6 Cost, Price, Revenue and Gross Margin of Radiopharmaceuticals 2012-2017 62
7 Major Manufacturers Analysis of Radiopharmaceuticals 64
7.1 Bayer 64
7.1.1 Company Profile 64
7.1.2 Product Information 65
7.1.3 Production, Price, Cost, Gross, and Revenue 65
7.2 Triad Isotopes 67
7.2.1 Company Profile 67
7.2.2 Product Information 68
7.2.3 Production, Price, Cost, Gross, and Revenue 68
7.3 Lantheus Medical Imaging 70
7.3.1 Company Profile 70
7.3.2 Product Information 71
7.3.3 Production, Price, Cost, Gross, and Revenue 71
7.4 GE Healthcare 73
7.4.1 Company Profile 73
7.4.2 Product Information 74
7.4.3 Production, Price, Cost, Gross, and Revenue 74
7.5 Mallinckrodt 76
7.5.1 Company Profile 76
7.5.2 Product Information 77
7.5.3 Production, Price, Cost, Gross, and Revenue 77
7.6 Eli Lilly 79
7.6.1 Company Profile 79
7.6.2 Product Information 80
7.6.3 Production, Price, Cost, Gross, and Revenue 80
7.7 Bracco Imaging 82
7.7.1 Company Profile 82
7.7.2 Product Information 83
7.7.3 Production, Price, Cost, Gross, and Revenue 84
7.8 SIEMENS 85
7.8.1 Company Profile 85
7.8.2 Product Information 87
7.8.3 Production, Price, Cost, Gross, and Revenue 87
7.9 Navidea 89
7.9.1 Company Profile 89
7.9.2 Product Information 90
7.9.3 Production, Price, Cost, Gross, and Revenue 90
7.10 Nordion 92
7.10.1 Company Profile 92
7.10.2 Product Information 93
7.10.3 Sales and Market Share 93
7.11 IBA Group 94
7.11.1 Company Profile 94
7.11.2 Product Information 95
7.11.3 Sales and Market Share 96
7.12 Jubilant Pharma 97
7.12.1 Company Profile 97
7.12.2 Product Information 98
7.12.3 Sales and Market Share 99
8 Price and Gross Margin Analysis 101
8.1 Analysis of Price 101
8.2 Gross Margin Analysis 101
8.3 Sales Price Comparison by Regions 102
8.4 Price Analysis of Different Radiopharmaceuticals Product Types 102
8.5 Gross Margin Analysis of Different Radiopharmaceuticals Applications 103
9 Marketing Trader or Distributor Analysis of Radiopharmaceuticals 104
9.1 Marketing Channels Status of Radiopharmaceuticals 104
9.2 Traders or Distributors of Radiopharmaceuticals with Contact Information 105
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Radiopharmaceuticals 106
9.4 United States Import, Export Analysis of Radiopharmaceuticals 106
10 Development Trend of Radiopharmaceuticals Industry 2017-2022 107
10.1 Capacity and Production Overview of Radiopharmaceuticals 2017-2022 107
10.2 Production Market Share by Product Types of Radiopharmaceuticals 2017-2022 108
10.3 Sales and Sales Revenue Overview of Radiopharmaceuticals 2017-2022 111
10.4 United States Sales of Radiopharmaceuticals by Applications 2017-2022 112
10.5 Import, Export and Consumption of Radiopharmaceuticals 2017-2022 113
10.6 Cost, Price, Revenue and Gross Margin of Radiopharmaceuticals 2017-2022 114
11 Industry Chain Suppliers of Radiopharmaceutical with Contact Information 115
11.1 Major Raw Materials Suppliers of Radiopharmaceutical with Contact Information 115
11.2 Manufacturing Equipment Suppliers of Radiopharmaceutical with Contact Information 116
11.3 Major Suppliers of Radiopharmaceuticals with Contact Information 116
11.4 Key Consumers of Radiopharmaceuticals with Contact Information 118
11.5 Supply Chain Relationship Analysis of Radiopharmaceutical 119
12 New Project Investment Feasibility Analysis of Radiopharmaceuticals 120
12.1 New Project SWOT Analysis of Radiopharmaceuticals 120
12.2 New Project Investment Feasibility Analysis of Radiopharmaceuticals 120
12.2.1 Project Name 120
12.2.2 Investment Budget 121
12.2.3 Project Product Solutions 121
12.2.4 Project Schedule 121
13 Conclusion of the United States Radiopharmaceutical Industry 2017 Market Research Report 123
14 Appendix 124
14.1 Methodology/Research Approach 124
14.1.1 Research Programs/Design 124
14.1.2 Market Size Estimation 125
14.1.3 Market Breakdown and Data Triangulation 126
14.2 Data Source 127
14.2.1 Secondary Sources 127
14.2.2 Primary Sources 128
14.3 Disclaimer 129
14.4 Author List 130

Tables and Figures

Figure Picture of Radiopharmaceuticals 1
Table Specifications of Radiopharmaceuticals 1
Table Specifications of Technetium-99m 2
Table Classification of Radiopharmaceuticals 3
Figure United States Production Market Share of Radiopharmaceuticals by Type in 2016 4
Figure Diagnostic Radioisotopes Picture 4
Table Diagnostic Nuclear Medicine / Radiopharmaceuticals Types 5
Figure Therapeutic Radioisotopes Picture 5
Table Application Fields of Radiopharmaceuticals Products 5
Figure 2016 United States Radiopharmaceuticals Major Applications Sales Share 6
Figure Oncology Examples 7
Figure Cardiology Examples 7
Figure Other Examples 8
Figure Industry Chain Structure of Radiopharmaceuticals 9
Figure United States Production Market Share of Radiopharmaceuticals by Region in 2016 10
Figure United States Sales Market Share of Radiopharmaceuticals by Region in 2016 11
Table FDA-approved Radiopharmaceuticals 11
Table Industry News List of Radiopharmaceuticals 12
Table Production Base and Market Concentration Rate of Raw Material 15
Table Equipment Suppliers Analysis of Radiopharmaceuticals 15
Figure USA Labor Cost Analysis 16
Figure Cost of Employing a Factory Worker 17
Table Average Price of Electricity to Ultimate Customers 2007-2016 18
Table Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2016 19
Figure Manufacturing Process Analysis of Radiopharmaceuticals 20
Figure United States Price Analysis of Radiopharmaceuticals 2012-2017 (USD/Dose) 21
Figure United States Cost Analysis of Radiopharmaceuticals 2012-2017 (USD/Dose) 21
Figure United States Gross Analysis of Radiopharmaceuticals 2012-2017 22
Table Capacity (M Doses) and Established Date of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 23
Table Headquarter of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 23
Table R&D Status/Revenue and Sales Region of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016 24
Table United States Production of Radiopharmaceuticals by Regions 2012-2017 (M Doses) 25
Table United States Production Market Share of Radiopharmaceuticals by Regions 2012-2017 25
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2012 26
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2013 26
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2014 27
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2015 27
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2016 28
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2017 28
Table United States Production of Radiopharmaceuticals by Product Types in 2012-2017 (M Doses) 29
Table United States Production Market Share of Radiopharmaceuticals by Product Types in 2012-2017 29
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2012 29
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2013 30
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2014 30
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2015 31
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2016 31
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2017 32
Table United States Sales of Radiopharmaceuticals by Applications 2012-2017 (M Doses) 32
Table United States Production Market Share of Radiopharmaceuticals by Applications 2012-2017 32
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2012 33
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2013 33
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2014 34
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2015 34
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2016 35
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2017 35
Figure Price Comparison of United States Radiopharmaceuticals Key Manufacturers in 2016 (USD/Dose) 36
Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue of Radiopharmaceuticals 2012-2017 36
Table United States Consumption Volume of Radiopharmaceuticals by Regions 2012-2017 (M Doses) 38
Table United States Consumption Volume Market Share of Radiopharmaceuticals by Regions 2012-2017 38
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2012 39
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2013 39
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2014 40
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2015 40
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2016 41
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2017 41
Table United States Consumption Value of Radiopharmaceuticals by Regions 2012-2017 (M USD) 42
Table United States Consumption Value Market Share of Radiopharmaceuticals by Regions 2012-2017 42
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2012 43
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2013 43
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2014 44
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2015 44
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2016 45
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2017 45
Table Consumption Price of Radiopharmaceuticals by Regions 2012-2017 (USD/Dose) 46
Table United States and Major Manufacturers Capacity of Radiopharmaceuticals 2012-2017 (M Doses) 47
Table United States Capacity Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017 47
Table United States and Major Manufacturers Production of Radiopharmaceuticals 2012-2017 (M Doses) 48
Table United States Production Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017 48
Table United States and Major Manufacturers Sales of Radiopharmaceuticals 2012-2017 (M Doses) 49
Table United States Sales Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017 49
Table United States and Major Manufacturers Revenue of Radiopharmaceuticals 2012-2017 (M USD) 50
Table United States Revenue Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017 50
Figure United States Capacity (M Doses), Production (M Doses) and Growth Rate of Radiopharmaceuticals 2012-2017 51
Figure United States Capacity Utilization Rate of Radiopharmaceuticals 2012-2017 51
Figure United States Sales Revenue (M USD) and Growth Rate of Radiopharmaceuticals 2012-2017 52
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2012 53
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2013 54
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2014 54
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2015 55
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2016 55
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2017 56
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2012 56
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2013 57
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2014 57
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2015 58
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2016 58
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2017 59
Figure United States Sales (M Doses) and Growth Rate of Radiopharmaceuticals 2012-2017 60
Table United States and Major Manufacturers Export of Radiopharmaceuticals 2012-2017 (M Doses) 61
Table United States Supply, Consumption and Gap of Radiopharmaceuticals 2012-2017 (M Doses) 61
Table United States Import, Export and Consumption of Radiopharmaceuticals 2012-2017 (M Doses) 62
Table Price of United States Radiopharmaceuticals Major Manufacturers 2012-2017 (USD/Dose) 62
Table Gross Margin of United States Radiopharmaceuticals Major Manufacturers 2012-2017 62
Table United States and Major Manufacturers Revenue of Radiopharmaceuticals 2012-2017 (M USD) 63
Table United States Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Radiopharmaceuticals 2012-2017 63
Table Bayer Company Profile 64
Figure Radiopharmaceuticals Product Picture of Bayer 65
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer (2012-2017) 65
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 66
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 66
Table Triad Isotopes Company Profile 67
Figure Radiopharmaceuticals Product Picture of Triad Isotopes 68
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Triad Isotopes (2012-2017) 68
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 69
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 69
Table Lantheus Medical Imaging Company Profile 70
Figure Radiopharmaceuticals Product Picture of Lantheus Medical Imaging 71
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Lantheus Medical Imaging (2012-2017) 71
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 72
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 72
Table GE Healthcare Company Profile 73
Figure Radiopharmaceuticals Product Picture of GE Healthcare 74
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GE Healthcare (2012-2017) 74
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 75
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 75
Table Mallinckrodt Company Profile 76
Figure Radiopharmaceuticals Product Picture of Mallinckrodt 77
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mallinckrodt (2012-2017) 77
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 78
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 78
Table Eli Lilly Company Profile 79
Figure Radiopharmaceuticals Product Picture of Eli Lilly 80
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly (2012-2017) 80
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 81
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 81
Table Bracco Imaging Company Profile 82
Figure Radiopharmaceuticals Product Picture of Bracco Imaging 83
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bracco Imaging (2012-2017) 84
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 84
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 85
Table SIEMENS Company Profile 85
Figure Radiopharmaceuticals Product Picture of SIEMENS 87
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of SIEMENS (2012-2017) 87
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 88
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 88
Table Navidea Company Profile 89
Figure Radiopharmaceuticals Product Picture of Navidea 90
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Navidea (2012-2017) 90
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017 91
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 91
Table Nordion Company Profile 92
Figure Radiopharmaceuticals Product Picture of Nordion 93
Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017 93
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 94
Table IBA Group Company Profile 94
Figure Radiopharmaceuticals Product Picture of IBA Group Healthcare 95
Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017 96
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 96
Table Jubilant Pharma Company Profile 97
Table Radiopharmaceuticals Product Picture of Jubilant Pharma 98
Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017 99
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017 100
Table Radiopharmaceuticals Price by Regions 2012-2017 (USD/Dose) 101
Table Radiopharmaceuticals Price by Companies 2012-2017 (USD/Dose) 101
Table Radiopharmaceuticals Gross Margin by Companies 2012-2017 101
Table Sales Price Comparison of Radiopharmaceuticals by Regions 2012-2017 (USD/Dose) 102
Table Price of Different Radiopharmaceuticals Product Types (USD/Dose) 102
Table Gross Margin of Different Radiopharmaceuticals Applications 103
Figure Marketing Channels Status of Radiopharmaceuticals 104
Table Traders or Distributors of Radiopharmaceuticals with Contact Information 105
Figure Ex-work Price, Channel Price and End Buyer Price of Radiopharmaceuticals (USD/Dose) in 2016 106
Table United States Import, Export of Radiopharmaceuticals (M Doses) 2012-2017 106
Figure United States Capacity (M Doses), Production (M Doses) and Growth Rate of Radiopharmaceuticals 2017-2022 107
Figure United States Capacity Utilization Rate of Radiopharmaceuticals 2017-2022 108
Table United States Radiopharmaceuticals Production by Product Types 2017-2022 (M Doses) 108
Table United States Radiopharmaceuticals Production Market Share by Product Types 2017-2022 108
Figure United States Production Market Share of Radiopharmaceuticals by Type in 2017 109
Figure United States Production Market Share of Radiopharmaceuticals by Type in 2022 110
Figure United States Sales (M Doses) and Growth Rate of Radiopharmaceuticals 2017-2022 111
Figure United States Sales Revenue (Million USD) and Growth Rate of Radiopharmaceuticals 2017-2022 111
Figure United States Sales of Radiopharmaceuticals by Applications 2017-2022 (M Doses) 112
Table United States Production Market Share of Radiopharmaceuticals by Applications 2017-2022 112
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2017 112
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2022 113
Table United States Production, Import, Export and Consumption of Radiopharmaceuticals 2017-2022 (M Doses) 113
Table United States Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Radiopharmaceuticals 2017-2022 114
Table Major Raw Materials Suppliers Analysis of Radiopharmaceuticals 115
Table Equipment Suppliers Analysis of Radiopharmaceuticals 116
Table Major Suppliers of Radiopharmaceuticals with Contact Information 116
Table Key Consumers of Radiopharmaceuticals with Contact Information 118
Figure Radiopharmaceuticals Supply Chain Analysis 119
Table New Project SWOT Analysis of Radiopharmaceuticals 120
Table Project Appraisal and Financing 121
Table New Project Construction Period 121
Table New Project Investment Feasibility Analysis of Radiopharmaceuticals 121
Table Research Programs/Design for This Report 124
Figure Bottom-up and Top-down Approaches for This Report 126
Figure Data Triangulation 127
Table Key Data Information from Secondary Sources 128
Table Key Data Information from Primary Sources 129